Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Systemic lupus erythematosus | R-HSA-977105 | map05322 | nefopam | 4450 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | prilocaine | 4906 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | prilocaine | 4906 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | prilocaine | 4906 | drug-path |
Gap junction | R-HSA-190861 | map04540 | prilocaine | 4906 | drug-path |
Long-term depression | R-HSA-9620244 | map04730 | prilocaine | 4906 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | prilocaine | 4906 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | prilocaine | 4906 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | prilocaine | 4906 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | prilocaine | 4906 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | prilocaine | 4906 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | prilocaine | 4906 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | prilocaine | 4906 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | metoclopramide | 4168 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | metoclopramide | 4168 | drug-path |
Adipocytokine signaling pathway | R-HSA-168638 | map04920 | metoclopramide | 4168 | drug-path |
ABC transporters | R-HSA-1369007 | map02010 | metoclopramide | 4168 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | metoclopramide | 4168 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | hydralazine | 5365247 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | hydralazine | 5365247 | drug-path |